BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uchida J, Kosoku A, Naganuma T, Tanaka T, Nakatani T. Latest insights on ABO-incompatible living-donor renal transplantation. Int J Urol 2020;27:30-8. [PMID: 31522462 DOI: 10.1111/iju.14109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients. Sci Rep 2022;12:5876. [PMID: 35393481 DOI: 10.1038/s41598-022-09897-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sharif A. Who Benefits From ABO-Incompatible Kidney Transplantation in the Contemporary Era? Am J Kidney Dis 2020;76:607-9. [PMID: 32771282 DOI: 10.1053/j.ajkd.2020.05.020] [Reference Citation Analysis]
3 Wang X, Zhang F, Jiang Y, Xu Z, Feng X, Li L, Fan Y, Song T, Shi Y, Huang Z, Lin T. Highly individual- and tissue-specific expression of glycoprotein group A and B blood antigens in the human kidney and liver. BMC Immunol 2021;22:66. [PMID: 34598667 DOI: 10.1186/s12865-021-00456-2] [Reference Citation Analysis]
4 Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, Suzuki Y, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Narumi S, Tomita H, Ohyama C. Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function. Transplantation Proceedings 2020;52:1723-8. [DOI: 10.1016/j.transproceed.2020.01.157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Soma O, Hatakeyama S, Yoneyama T, Saito M, Sasaki H, Tobisawa Y, Noro D, Suzuki Y, Tanaka M, Nishimura SI, Harada H, Ishida H, Tanabe K, Satoh S, Ohyama C. Serum N-glycan profiling can predict biopsy-proven graft rejection after living kidney transplantation. Clin Exp Nephrol 2020;24:174-84. [PMID: 31768865 DOI: 10.1007/s10157-019-01820-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Medina-Pestana J, Abbud-Filho M, Garcia VD, Foresto RD, Requião-Moura LR. Paired kidney donation: are we going beyond reasonable limits in living-donor transplantation? J Bras Nefrol 2022:S0101-28002022005003402. [PMID: 35051260 DOI: 10.1590/2175-8239-JBN-2021-0230] [Reference Citation Analysis]
7 Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, Suzuki Y, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Narumi S, Tomita H, Ohyama C. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan. Transplant Proc 2020;52:1700-4. [PMID: 32448659 DOI: 10.1016/j.transproceed.2020.01.152] [Reference Citation Analysis]
8 Zhang F, Yin S, Fan Y, Song T, Huang Z, Liang J, Wu J, Yang Y, Lin T, Wang X. Effect of Donor and Recipient ABH-Secretor Status on ABO-Incompatible Living Donor Kidney Transplantation. Front Immunol 2021;12:671185. [PMID: 34194432 DOI: 10.3389/fimmu.2021.671185] [Reference Citation Analysis]